Literature DB >> 20001800

Muc4/MUC4 functions and regulation in cancer.

Kermit L Carraway1, George Theodoropoulos, Goldi A Kozloski, Coralie A Carothers Carraway.   

Abstract

The membrane mucin MUC4 (human) is abundantly expressed in many epithelia, where it is proposed to play a protective role, and is overexpressed in some epithelial tumors. Studies on the rat homologue, Muc4, indicate that it acts through anti-adhesive or signaling mechanisms. In particular, Muc4/MUC4 can serve as a ligand/modulator of the receptor tyrosine kinase ErbB2, regulating its phosphorylation and the phosphorylation of its partner ErbB3, with or without the involvement of the ErbB3 ligand neuregulin. Muc4/MUC4 can also modulate cell apoptosis via multiple mechanisms, both ErbB2 dependent and independent. Muc4/MUC4 expression is regulated by multiple mechanisms, ranging from transcriptional to post-translational. The roles of MUC4 in tumors suggest that it may be valuable as a tumor marker or target for therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20001800      PMCID: PMC2825673          DOI: 10.2217/fon.09.125

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  83 in total

1.  Characterization of human mucin gene MUC4 promoter: importance of growth factors and proinflammatory cytokines for its regulation in pancreatic cancer cells.

Authors:  M Perrais; P Pigny; M P Ducourouble; D Petitprez; N Porchet; J P Aubert; I Van Seuningen
Journal:  J Biol Chem       Date:  2001-06-19       Impact factor: 5.157

2.  Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways.

Authors:  Scott Jepson; Masanobu Komatsu; Bushra Haq; Maria E Arango; Daming Huang; Coralie A Carothers Carraway; Kermit L Carraway
Journal:  Oncogene       Date:  2002-10-24       Impact factor: 9.867

3.  Sialomucin complex (rat Muc4) is regulated by transforming growth factor beta in mammary gland by a novel post-translational mechanism.

Authors:  S A Price-Schiavi; X Zhu; R Aquinin; K L Carraway
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

4.  IL-9 modulated MUC4 gene and glycoprotein expression in airway epithelial cells.

Authors:  Gautam Damera; Baoyun Xia; Hanumatha R Ancha; Goverdhan P Sachdev
Journal:  Biosci Rep       Date:  2006-02       Impact factor: 3.840

5.  Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).

Authors:  Subhash C Chauhan; Ajay P Singh; Fernanda Ruiz; Sonny L Johansson; Maneesh Jain; Lynette M Smith; Nicolas Moniaux; Surinder K Batra
Journal:  Mod Pathol       Date:  2006-07-28       Impact factor: 7.842

6.  SMAD2 and SMAD7 involvement in the post-translational regulation of Muc4 via the transforming growth factor-beta and interferon-gamma pathways in rat mammary epithelial cells.

Authors:  Pedro Soto; Shari A Price-Schiavi; Kermit L Carraway
Journal:  J Biol Chem       Date:  2003-03-31       Impact factor: 5.157

7.  TGFbeta regulation of membrane mucin Muc4 via proteosome degradation.

Authors:  Wieslawa M Lomako; Joseph Lomako; Pedro Soto; Coralie A Carothers Carraway; Kermit L Carraway
Journal:  J Cell Biochem       Date:  2009-07-01       Impact factor: 4.429

8.  Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1.

Authors:  Michaël Perrais; Pascal Pigny; Marie-Christine Copin; Jean-Pierre Aubert; Isabelle Van Seuningen
Journal:  J Biol Chem       Date:  2002-06-19       Impact factor: 5.157

9.  MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes.

Authors:  Donald T Weed; Carmen Gomez-Fernandez; Mohammed Yasin; Kara Hamilton-Nelson; Michael Rodriguez; Jin Zhang; Kermit L Carraway
Journal:  Laryngoscope       Date:  2004-08       Impact factor: 3.325

10.  Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway.

Authors:  Christophe Mariette; Michaël Perrais; Emmanuelle Leteurtre; Nicolas Jonckheere; Brigitte Hémon; Pascal Pigny; Surinder Batra; Jean-Pierre Aubert; Jean-Pierre Triboulet; Isabelle Van Seuningen
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

View more
  38 in total

1.  Mechanistic and signaling analysis of Muc4-ErbB2 signaling module: new insights into the mechanism of ligand-independent ErbB2 activity.

Authors:  Goldi A Kozloski; Coralie A Carothers Carraway; Kermit L Carraway
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

2.  Untouchable genes in the human genome: Identifying ideal targets for cancer treatment.

Authors:  Ivan P Gorlov; Olga Y Gorlova; Christopher I Amos
Journal:  Cancer Genet       Date:  2019-01-24

Review 3.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

4.  MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells.

Authors:  Sanjeev K Srivastava; Arun Bhardwaj; Seema Singh; Sumit Arora; Bin Wang; William E Grizzle; Ajay P Singh
Journal:  Carcinogenesis       Date:  2011-10-07       Impact factor: 4.944

Review 5.  Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.

Authors:  Muzafar A Macha; Shiv Ram Krishn; Rahat Jahan; Kasturi Banerjee; Surinder K Batra; Maneesh Jain
Journal:  Cancer Treat Rev       Date:  2015-01-14       Impact factor: 12.111

6.  Transmembrane mucins as novel therapeutic targets.

Authors:  Pamela E Constantinou; Brian P Danysh; Neeraja Dharmaraj; Daniel D Carson
Journal:  Expert Rev Endocrinol Metab       Date:  2011-11

Review 7.  Clinicopathological and prognostic significance of MUC4 expression in cancers: evidence from meta-analysis.

Authors:  Xing Huang; Xin Wang; Shi-Ming Lu; Chen Chen; Jie Wang; Yan-Yan Zheng; Bin-Hui Ren; Lin Xu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

8.  Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.

Authors:  Kristin E Haugstad; Bjørn T Stokke; C Fred Brewer; Thomas A Gerken; Marit Sletmoen
Journal:  Glycobiology       Date:  2014-12-19       Impact factor: 4.313

9.  miR-581-Related Single Nucleotide Polymorphism, rs2641726, Located in MUC4 Gene, is Associated with Gastric Cancer Incidence.

Authors:  Fariba Nabatchian; Mahdis Rahimi Naiini; Afshin Moradi; Hossein Tabatabaeian; Negin Hoghoughi; Mansoureh Azadeh; Kamran Ghaedi
Journal:  Indian J Clin Biochem       Date:  2018-04-10

10.  MicroRNA Profile to Predict Gemcitabine Resistance in Bladder Carcinoma Cell Lines.

Authors:  Spencer I Kozinn; Niall J Harty; Jessica M Delong; Christina Deliyiannis; Tanya Logvinenko; Ian C Summerhayes; John A Libertino; Antonia H Holway; Kimberly M Rieger-Christ
Journal:  Genes Cancer       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.